Company Filing History:
Years Active: 2021
Title: Joaquin Arribas: Innovator in Bispecific T Cell Activating Molecules
Introduction
Joaquin Arribas is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of immunology through his innovative work on bispecific antigen binding molecules. His research focuses on enhancing T cell activation and directing these cells to specific target cells, which has important implications for disease treatment.
Latest Patents
Joaquin Arribas holds a patent for "Bispecific T cell activating antigen binding molecules." This invention relates to novel bispecific antigen binding molecules designed for T cell activation and redirection. The patent also covers polynucleotides encoding these molecules, as well as vectors and host cells that incorporate such polynucleotides. Furthermore, the invention outlines methods for producing these bispecific antigen binding molecules and their applications in treating various diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Joaquin Arribas has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Joaquin has collaborated with notable colleagues such as Christian Klein and Marina Bacac. These partnerships have enriched his research and expanded the impact of his innovations in the field of immunotherapy.
Conclusion
Joaquin Arribas is a distinguished inventor whose work on bispecific T cell activating molecules represents a significant advancement in immunology. His contributions have the potential to transform treatment approaches for various diseases, showcasing the importance of innovation in the medical field.